Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030305 (
pancreatitis
)
16,014
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
L-Asparaginase is an enzyme successfully being used in the treatment of acute lymphoblastic leukemia, acute myeloid leukemia, and
non-Hodgkin's lymphoma
. However, some disadvantages still limit its full application potential, e.g., allergic reactions,
pancreatitis
, and blood clotting impairment. Therefore, much effort has been directed at improving its performance. A popular strategy is to randomly conjugate L-asparaginase with mono-methoxy polyethylene glycol, which became a commercial FDA approved formulation widely used in recent years. To improve this formulation by PEGylation, herein we performed cysteine-directed conjugation of the L-asparaginase subunits to prevent dissociation-induced loss of activity. The recombinant cysteine conjugation sites were introduced by mutagenesis at surface-exposed positions on the protein to avoid affecting the catalytic activity. Three conjugates were obtained using different linear PEGs of 1000, 2000, and 5000 g/mol, with physical properties ranging from a semi-solid gel to a fully soluble state. The soluble-conjugate exhibited higher catalytic activity than the non-conjugated mutant, and the same activity than the native enzyme. The cysteine-directed crosslinking of the L-asparaginase subunits produced a higher molecular weight conjugate compared to the native tetrameric enzyme. This strategy might improve L-asparaginase efficiency for leukemia treatment by reducing glomerular filtration due to the increase in hydrodynamic size thus extending half-live, while at the same time retaining full catalytic activity.
...
PMID:Thiol-maleimide poly(ethylene glycol) crosslinking of L-asparaginase subunits at recombinant cysteine residues introduced by mutagenesis. 3005 38
As the use of contrast-enhanced ultrasound (CEUS) is still relatively novel but quickly expanding, we would like to present a series of clinical cases where CEUS was used in diagnostics of pediatric patients. The presented cases include kidney trauma,
non-Hodgkin's lymphoma
with secondary liver deposits, renal cortical cysts, retropharyngeal abscess, necrotizing
pancreatitis
, and vesicoureteral reflux. The wide range of the presented cases demonstrates CEUS' multipurpose use, which, together with its other useful attributes, especially its favorable safety profile, makes it an excellent diagnostic tool.
...
PMID:The Use of Contrast-enhanced Ultrasound in Pediatrics: A Case Series. 3189 Apr 16
<< Previous
1
2